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Abstract 
Introduction: Acute dyspnea is a common cause of hospitalization in emergency departments (ED).Distinguishing 
the cardiac causes of acute dyspnea from pulmonary ones is a major challenge for responsible physicians in EDs. 
This study compares the characteristics of bedside ultrasonography with serum level of blood natriuretic peptide 
(BNP) in this regard. Methods: This diagnostic accuracy study compares bedside ultrasonography with serum BNP 
levels in differentiating cardiogenic causes of acute respiratory distress. Echocardiography was considered as the 
reference test. A checklist including demographic data (age and sex), vital signs, medical history, underlying dis-
eases, serum level of BNP, as well as findings of chest radiography, chest ultrasonography, and echocardiography 
was filled for all patients with acute onset of dyspnea. Screening characteristics of the two studied methods were 
calculated and compared using SPSS software, version 20. Results: 48 patients with acute respiratory distress were 
evaluated (50% female). The mean age of participants was 66.94 ± 16.33 (28-94) years. Based on the results of 
echocardiography and final diagnosis, the cause of dyspnea was cardiogenic in 20 (41.6%) cases. Bedside ultraso-
nography revealed the cardiogenic cause of acute dyspnea in 18 cases (0 false positive) and BNP in 44 cases (24 
false positives). The area under the ROC curve for bedside ultrasonography and BNP for differentiating the cardio-
genic cause of dyspnea were 86.4 (95% CI: 74.6-98.3) and 66.3 (95% CI: 49.8-89.2), respectively (p = 0.0021). 
Conclusion: It seems that bedside ultrasonography could be considered as a helpful and accurate method in dif-
ferentiating cardiogenic causes of acute dyspnea in emergency settings. Nevertheless, more study is needed to 
make a runaway algorithm to evaluate patients with respiratory distress using bedside ultrasonography, which 
leads to rapid therapeutic decisions in a short time. 
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Introduction: 
 cute dyspnea is a common cause of hospitaliza-
tion in emergency departments (ED) (1). There 
are some clinical and para clinical measures such 
as patients’ history, physical examination and bedside 
ultrasonography that help physicians differentiate car-
diac causes of acute respiratory distress from pulmonary 
ones. Some have introduced diagnostic rules such as the 
Framingham heart failure criteria. But, due to their low 
sensitivity and high specificity, they cannot distinguish 
acute heart failure from non-cardiac causes well (2). On 
the other hand, the sensitivity of electrocardiography 
(ECG) and bedside ultrasonography are not high enough 
to exclude the presence of cardiogenic pulmonary 
edema, as well (2, 3). Conventional echocardiography is 
an important diagnostic tool for screening and diagnos-
ing heart failure but it is not available 24 hours a day and 
7 days a week, additionally it needs many training time 
for skillful application. Brain natriuretic peptide (BNP) 
or N-terminal of the pro-hormone brain natriuretic pep-
tide (NT-pro-BNP) has been shown to be able to rule out 
or establish the diagnosis of cardiogenic causes of acute 
respiratory distress (1). But, some diseases such as renal 
failure, critical illness, pulmonary heart disease, arrhyth-
mia, anemia, valvular heart diseases and muscular dis-
eases can affect the results of BNP measures (1, 4). Now-
adays, bedside ultrasonography is integrated into the 
daily practice of emergency physicians, which helps 
them ameliorate the accuracy of their diagnoses and 
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lung pathologies in a short period of time, by interpret-
ing the artifacts such as comet tails. These artifacts have 
high sensitivity, but low specificity in diagnosing pulmo-
nary edema (5-7). In this study, we compare bedside ul-
trasonography with BNP in differentiating cardiogenic 




This diagnostic accuracy study compares bedside ultra-
sonography with serum BNP levels in differentiating car-
diogenic cause of acute respiratory distress from pulmo-
nary sources. Echocardiography was considered as the 
reference test. The study was conducted in the emer-
gency department of Al-Zahra Hospital, Isfahan, Iran, 
with more than 80000 patients admitted to the ED annu-
ally and a 40% admission rate. Before the initiation of 
the study, a 10-day local workshop was taught by a 
board-certified attending emergency medicine physician 
and a cardiologist, focusing on bedside ultrasonography 
with both didactic and hands-on trainings. At the time of 
admission, we obtained a written informed consent from 
participants or their legal guardians. The research was 
approved by institutional review board of ethic commit-
tee.  
Participants 
The study population consisted of those who were ad-
mitted to the ED with acute onset of dyspnea between 
November 2013 and April 2014. Intubated and trau-
matic patients as well as patients with myocardial in-
fraction and history of end stage renal disease were ex-
cluded. In addition, cases with the serum creatinine 
level above the normal range during laboratory evalua-
tion were excluded. A checklist including demographic 
data (age and sex), vital signs, medical history, under-
lying diseases, serum level of BNP, as well as findings of 
chest radiography, chest ultrasonography, and echo-
cardiography was filled for all participants. 
Procedure 
Patients were enrolled with convenience sampling 
method. On admission, after history taking and physical 
examination, an echocardiogram and a bedside ultraso-
nography were performed, and a blood sample was 
drawn for laboratory examinations (including BNP lev-
els) during the first 15 minutes of admission. For meas-
uring BNP level (by Bayer Diagnostic ADVIA centaur 
BNP assay method) 2 ml of peripheral venous blood 
sample was sent to the laboratory in a vacuum tube 
containing EDTA. Bedside ultrasonography was done 
with an (MyLab 25 Gold 2009) ultrasound machine (Bi-
osound Esaote, Inc., Indianapolis, IN) using a CA430 
Curved Array (3.5-5 MHz) and a LA523 Linear Array 
transducer (5.0 to 13.0 MHz) by trained emergency 
medicine residents within 30 minutes of admission. 
The majority of patients were in sitting or supine posi-
tion in accordance with their comfort position. At first, 
ejection fraction (EF) of heart was estimated visually, 
via four-chamber, two-chamber, long axis and short 
axis views of the heart. EF was classified as good in case 
of EF ≥ 40% and low when EF was less than 40%. For 
performing ultrasonography, each hemi thorax was di-
vided into 2 anterior (upper and lower) and 2 lateral 
zones. Anterior zone was the area between sternum 
and anterior axillary line while lateral zone was be-
tween anterior and posterior axillary lines. These zones 
were divided into upper and lower zones by the third 
intercostal space as a border. Lungs were scanned for 
presence of pleural sliding, B-Lines and A-Lines. Pleural 
sliding is the back and forth movement of visceral and 
parietal pleura. B-Lines are vertical pleural-based dis-
crete, laser-like, hyper-echoic reverberation artifacts. 
They move with respiration simultaneously and extend 
to the bottom of the screen without fading. A-Lines are 
horizontal hyper-echoic reverberation lung artifacts 
that are separated from each other by an equal dis-
tance. For differentiating diastolic heart failure from 
pulmonary causes of acute respiratory distress, inferior 
vena cava (IVC) collapsibility index was measured. IVC 
collapsibility was defined as follows: maximum axial di-
ameter of IVC minus minimum axial diameter of IVC di-
vided by maximum axial diameter of IVC (IVCmax- 
IVCmin/IVCmax). IVC diameters were measured at 2-3 
centimeters from the right atrium, during expiration 
(IVCmax) and inspiration (IVCmin) with a curvilinear 
probe located longitudinally on sub-xyphoid area. Dias-
tolic dysfunction was considered as source of acute 
dyspnea if EF was lower than 40% or EF was more than 
40% but IVC collapsibility index was lower than 50%. 
Ultrasonography performance took 6 minutes for each 
patient. All echocardiography were performed by an 
expert cardiologist, who was blinded to clinical situa-
tion of patients. Final diagnosis of patients was decided 
based on clinical, laboratory, imaging and response to 
treatment findings by an expert cardiologist together 
with an internist. 
Statistical analysis 
Total sample size of this study was estimated 48 cases 
(Zα = 95%, p= 50%, d =15%). Data analysis was per-
formed using SPSS software, version 20. Quantitative 
data were reported as frequency and percentage, and 
qualitative ones as mean and standard deviation. Sen-
sitivity, specificity, positive predictive value (PPV) and 
negative predictive value (NPV) of bedside ultrasonog-
raphy compared to BNP in differentiating cardiogenic 
causes of acute dyspnea were calculated. In addition, 
area under the receiver operating characteristic (ROC) 
curve with 95% confidence interval (CI) was calculated 
for the two diagnostic tests. Chi-square, Fisher’s exact 
test, and t-test were used for comparing the discrete 
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and continuous variables. P-value < 0.05 was consid-
ered statistically significant. 
 
Results: 
48 patients with acute respiratory distress were evalu-
ated (50% female). The mean age of participants was 
66.94 ± 16.33 (28-94) years. Table 1 compares baseline 
characteristics of the studied patients. Based on the re-
sults of echocardiography and final diagnosis, the cause 
of dyspnea was cardiogenic in 20 (41.6%) cases.  
Bedside ultrasonography revealed the cardiogenic cause 
of acute dyspnea in 18 cases (0 false positive) and BNP 
in 44 cases (24 false positives). Table 2 summarizes final 
diagnosis of patients based on imaging, laboratory, and 
clinical findings.  
Final diagnosis of patients regarding the source of dysp-
nea was 100% compatible with echocardiographic re-
sults. The area under the ROC curve for bedside ultraso-
nography and BNP for differentiating the cardiogenic 
cause of dyspnea were 86.4 (95% CI: 74.6-98.3) and 66.3 
(95% CI: 49.8-89.2), respectively (Figure 1, p = 0.0021). 
Table 3 summarizes the screening performance charac-
teristics of the two studied diagnostic tests. 
 
Discussion: 
Based on the results of the present study, bedside ultra-
sonography had better screening performance charac-
teristics compared to BNP in detection of cardiogenic 
causes of dyspnea. The comparison of area under the 
ROC curve for the two tests showed significant accuracy 
of bedside ultrasonography in this regard. The causes of 
acute dyspnea divide into major categories of cardiac 
and non-cardiac. Distinguishing between these two cat-
egories is the first step in choosing therapeutic approach 
and still remains as one of the frequent challenges of 
emergency physicians. In this regard, some facilities 
such as BNP measurement and echocardiography can be 
helpful (8). Multiple studies have shown high diagnostic 
accuracy of serum BNP in ruling out heart failure as a 
cause of acute dyspnea (9-12). Yet, the high rate of car-
diac and renal dysfunction in critically ill patients limits 
the discriminative role of BNP. In the present study, the 
sensitivity of BNP in 703 pg/ml cut-off was 70% while 
Arques et al. showed 86.4% and 68% sensitivity of BNP 
in 253 pg/ml and 480 pg/mL cut-offs, respectively (13). 
Serum BNP ≥ 22 pmol/L precisely reflected the final di-
agnosis of heart failure with 93% sensitivity and 90% 
specificity in Davis et al. study (14). In contrast to several 
studies in this regard, the accuracy of BNP in the present 
study was slightly low (15-18). This could be explained 
by the different cut-offs used for BNP in different studies. 
The accuracy of bedside ultrasonography in prediction 
of cardiac origin of dyspnea was known to be high (1).   
Table 1: Baseline characteristics of participants based on cause of dyspnea 
Characteristics 
Cause of dyspnea  
P-value 
Cardiogenic Non-Cardiogenic 
Age (year) 64.7±21.2 68.1±13.8 0.6 
Sex    
Male 9 (37.5) 15 (62.5) 0.55 
Female 11 (45.8) 13 (54.2)  
History of CHF*    
Yes 5 (35.7) 9 (64.3) 0.748 
No 15 (45.5) 18 (54.5)  
Coronary artery disease    
Yes 14 (43.8) 18 (56.3) 0.763 
No 6 (37.5) 10 (62.5)  
COPD*    
Yes 4 (44.4) 5 (55.6) 1.000 
No 16 (41) 23 (59)  
Asthma    
Yes 1 (33.3) 2 (66.7) 1.000 
No 19 (42.2) 26 (57.8)  
Hypertension    
Yes 6 (40) 9 (60) 1.000 
No 14 (42.4) 19 (57.6)  
Jugular venous distension    
Yes 3 (30) 7 (70) 0.488 
No 17 (44.7) 23 (55.3)  
Brain natriuretic peptide (pg/ml)  2819±4095 1433±3029 0.184 
Ejection fraction (%) 48±12 40±13 0.04 
 
Table 2: Final diagnosis of patients based on imaging, la-
boratory, clinical findings, and response to treatment 
Diagnosis Number (%) 
Asthma 3 (3.6) 
Pulmonary edema 19 (39.6) 
Pulmonary thromboembolism 10 (20.8) 
Pneumonia 4 (8.3) 
Myocardial infraction 3 (6.3) 
COPD* 5 (10.4) 
Pleural effusion 1 (2.1) 
Emotional 1 (2.1) 
*COPD: Chronic obstructive pulmonary disease. 
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 Ultrasonography is more accurate in distinguishing free 
pleural effusion (19). In the majority of studies, bedside 
ultrasonography was performed by experienced opera-
tors within 10 minutes, and many studies claim comple-
tion of the exam within 3-5 minutes (20). In a study by 
Gargani et al. bedside ultrasonography in patients with 
acute dyspnea significantly correlated with their BNP val-
ues (1). Ultrasonography was shown to be accurate for 
differentiating cardiogenic acute dyspnea from those 
caused by primary pulmonary disease in the emergency 
setting (21). Multiple B-lines have been 100% sensitive 
and 92% specific in the diagnosis of pulmonary edema 
(22). In addition, the finding of diffuse multiple B-lines in 
bedside ultrasonography has had 95% specificity and 
97% sensitivity in diagnosis of cardiogenic pulmonary 
edema (23). If these findings are confirmed in a large 
number of patients, bedside ultrasonography could be-
come a valuable tool for situations where BNP is not avail-
able or in settings where other techniques are not readily 
available such as remote area, or even in out-of-hospital 
settings. If we use BNP along with bedside ultrasonogra-
phy in order to optimize its diagnostic potential, we could 
reach the final diagnosis in less time. Yet, in addition to op-
erator dependency, ultrasonography has some limitations 
such as application difficulties in obese patients, ribcage, 
and presence of subcutaneous emphysema (24). 
 
Conclusion: 
It seems that bedside ultrasonography could be consid-
ered as a helpful and accurate method in differentiating 
cardiogenic causes of acute dyspnea in emergency set-
tings. Nevertheless, more study is needed to make a run-
away algorithm to evaluate patients with respiratory 
distress using bedside ultrasonography, which leads to 
rapid therapeutic decisions in a short time.  
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